Cited by 734Nanoparticle-Based Drug DeliveryCancer Cells and MetastasisCellular Mechanics and Interactions

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Open access

Diop-Frimpong, Benjamin, Chauhan, Vikash P., Krane, Stephen, Boucher, Yves, Jain, Rakesh K.·2011·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1018892108PMC PMC3041115

Open this paper in CoChat — free account Open PDF

Abstract

The dense collagen network in tumors significantly reduces the penetration and efficacy of nanotherapeutics. We tested whether losartan—a clinically approved angiotensin II receptor antagonist with noted antifibrotic activity—can enhance the penetration and efficacy of nanomedicine. We found that losartan inhibited collagen I production by carcinoma-associated fibroblasts isolated from breast cancer biopsies. Additionally, it led to a dose-dependent reduction in stromal collagen in desmoplastic models of human breast, pancreatic, and skin tumors in mice. Furthermore, losartan improved the distribution and therapeutic efficacy of intratumorally injected oncolytic herpes simplex viruses. Finally, it also enhanced the efficacy of i.v. injected pegylated liposomal doxorubicin (Doxil). Thus, losartan has the potential to enhance the efficacy of nanotherapeutics in patients with desmoplastic tumors.

Integrity signals

Registry

Crossref · 10.1073/pnas.1018892108

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Self-citation
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Collagens—structure, function, and biosynthesis
Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,777
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Self-citation
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 844
Self-citation

Show all 54 references

Sorted by citations

Items 201–300 of 734

Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine
Liu, J., Tian, L., Zhang, R., Dong, Z., Wang, H., & Liu, Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17684 · Cited by 74
The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers
Kozlova, N., Grossman, J. E., Iwanicki, M. P., & Muranen, T. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.001 · Cited by 73
Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
Chen, J., Ding, Z., Li, S., Liu, S., Xiao, C., Li, Z., Zhang, B., Chen, X., & Yang, X. (2020) · Theranostics · doi:10.7150/thno.51383 · Cited by 77
Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy
Xu, X., Wu, Y., Qian, X., Wang, Y., Wang, J., Li, J., Li, Y., & Zhang, Z. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101428 · Cited by 75
The importance of being CAFs (in cancer resistance to targeted therapies)
Rizzolio, S., Giordano, S., & Corso, S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02524-w · Cited by 75
Extracellular matrix: unlocking new avenues in cancer treatment
Lee, J. J., Ng, K. Y., & Bakhtiar, A. (2025) · Biomarker Research · doi:10.1186/s40364-025-00757-3 · Cited by 83
Just so stories: The random acts of anti-cancer nanomedicine performance
Moghimi, S. M., & Farhangrazi, Z. S. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.04.011 · Cited by 75
Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(d,l-lactic acid)
Wang, G., Chen, Y., Wang, P., Wang, Y., Hong, H., Li, Y., Qian, J., Yuan, Y., Yu, B., & Liu, C. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.10.017 · Cited by 76
Strategies for improving drug delivery: nanocarriers and microenvironmental priming
Khalid, A., Persano, S., Shen, H., Zhao, Y., Blanco, E., Mauro Ferrari, B., & Wolfram, J. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1243527 · Cited by 77
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Lan, X., Li, W., Zhao, K., Wang, J., Li, S., & Hai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582532 · Cited by 75
Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors
Han, X., Xu, Y., Geranpayehvaghei, M., Anderson, G. J., Li, Y., & Nie, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119745 · Cited by 74
Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment
Kang, T., Zhu, Q., Jiang, D., Feng, X., Feng, J., Jiang, T., Yao, J., Jing, Y., Song, Q., Jiang, X., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.037 · Cited by 70
Obesity and Cancer: An Angiogenic and Inflammatory Link
Fukumura, D., Incio, J., Shankaraiah, R. C., & Jain, R. K. (2016) · Microcirculation · doi:10.1111/micc.12270 · Cited by 69
Self-citation
Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 76
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets
Lappano, R., Rigiracciolo, D. C., Belfiore, A., Maggiolini, M., & Francesco, E. M. D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1751819 · Cited by 71
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling
Hori, D., Dunkerly-Eyring, B. L., Nomura, Y., Biswas, D., Steppan, J., Henao‐Mejia, J., Adachi, H., Santhanam, L., Berkowitz, D. E., Steenbergen, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174108 · Cited by 68
Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas
Jiang, T., Zhang, B., Shen, S., Tuo, Y., Luo, Z., Hu, Y., Pang, Z., & Jiang, X. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09458 · Cited by 69
Mild Acid-Responsive “Nanoenzyme Capsule” Remodeling of the Tumor Microenvironment to Increase Tumor Penetration
Yao, H., Guo, X., Zhou, H., Ren, J., Li, Y., Duan, S., Gong, X., & Du, B. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c03022 · Cited by 68
Poly (2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors
Seo, Y., Schulz, A., Han, Y., He, Z., Bludau, H., Wan, X., Tong, J., Bronich, T. K., Sokolsky, M., Luxenhofer, R., et al. (2015) · Polymers for Advanced Technologies · doi:10.1002/pat.3556 · Cited by 67
Targeting Tumors Using Peptides
Scodeller, P., & Asciutto, E. K. (2020) · Molecules · doi:10.3390/molecules25040808 · Cited by 65
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Bartolucci, D., Montemurro, L., Raieli, S., Lampis, S., Pession, A., Hrelia, P., & Tonelli, R. (2022) · Cancers · doi:10.3390/cancers14184421 · Cited by 70
MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy
Wei, Y., Song, S., Duan, N., Wang, F., Wang, Y.-X., Yang, Y., Peng, C., Li, J., Nie, D., Zhang, X., et al. (2020) · Advanced Science · doi:10.1002/advs.201902746 · Cited by 66
Extracellular matrix proteins regulate NK cell function in peripheral tissues
Bunting, M. D., Vyas, M., Requesens, M., Langenbucher, A., Schiferle, E. B., Manguso, R. T., Lawrence, M. S., & Demehri, S. (2022) · Science Advances · doi:10.1126/sciadv.abk3327 · Cited by 67
Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors
Al-Abd, A. M., Aljehani, Z. K., Gazzaz, R. W., Fakhri, S. H., Jabbad, A. H., Alahdal, A. M., & Torchilin, V. P. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.055 · Cited by 67
Inhibition of tumor-promoting stroma to enforce subsequently targeting AT1R on tumor cells by pathological inspired micelles
Zhu, Y., Wen, L., Shao, S., Tan, Y., Meng, T., Yang, X., Liu, Y., Liu, X., Yuan, H., & Hu, F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.023 · Cited by 66
A Dynamic 3D Tumor Spheroid Chip Enables More Accurate Nanomedicine Uptake Evaluation
Zhuang, J., Zhang, J., Wu, M., & Zhang, Y. (2019) · Advanced Science · doi:10.1002/advs.201901462 · Cited by 65
Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review
Najafi, M., Tavakol, S., Zarrabi, A., & Ashrafizadeh, M. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1773864 · Cited by 65
Hybrid pH-sensitive nanogels surface-functionalized with collagenase for enhanced tumor penetration
Wang, X., Luo, J., He, L., Cheng, X., Yan, G., Wang, J., & Tang, R. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.04.084 · Cited by 65
A bioengineered heterotypic stroma–cancer microenvironment model to study pancreatic ductal adenocarcinoma
Drifka, C. R., Eliceiri, K. W., Weber, S. M., & Kao, W. J. (2013) · Lab on a Chip · doi:10.1039/c3lc50487e · Cited by 64
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments
Yokoi, K., Tanei, T., Godin, B., van de Ven, A. L., Hanibuchi, M., Matsunoki, A., Alexander, J. F., & Mauro Ferrari, B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.015 · Cited by 64
Within tumors, interactions between T cells and tumor cells are impeded by the extracellular matrix
Salmon, H., & Donnadieu, E. (2012) · OncoImmunology · doi:10.4161/onci.20239 · Cited by 64
Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
Hilmi, M., Nicolle, R., Bousquet, C., & Neuzillet, C. (2020) · Cancers · doi:10.3390/cancers12102969 · Cited by 66
An update on dual targeting strategy for cancer treatment
Taghipour, Y. D., Zarebkohan, A., Salehi, R., Rahimi, F., Torchilin, V. P., Hamblin, M. R., & Seifalian, A. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.044 · Cited by 69
The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis
Yu, S., Wang, S., Wang, X., & Xu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03518-8 · Cited by 70
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
Geretti, E., Leonard, S. C., Dumont, N., Lee, H., Zheng, J., Souza, R. D., Gaddy, D. F., Espelin, C. W., Jaffray, D. A., Moyo, V. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0314 · Cited by 62
Compressive Remodeling Alters Fluid Transport Properties of Collagen Networks – Implications for Tumor Growth
Ferruzzi, J., Sun, M., Gkousioudi, A., Pilvar, A., Roblyer, D. M., Zhang, Y., & Zaman, M. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-50268-z · Cited by 60
Exosomes are the Driving Force in Preparing the Soil for the Metastatic Seeds: Lessons from the Prostate Cancer
Saber, S. H., Ali, H. E. A., Gaballa, R., Gaballah, M. S. A., Ali, H. I., Zerfaoui, M., & Elmageed, Z. Y. A. (2020) · Cells · doi:10.3390/cells9030564 · Cited by 63
Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments
Perini, M. V., Dmello, R. S., Nero, T. L., & Chand, A. L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107527 · Cited by 62
Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions
Catarata, M. J., Ribeiro, R. J. T., Oliveira, M. J., Cordeiro, C. R., & Medeiros, R. (2020) · Cancers · doi:10.3390/cancers12061457 · Cited by 62
Improving nanotherapy delivery and action through image-guided systems pharmacology
Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Theranostics · doi:10.7150/thno.37215 · Cited by 60
The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions
Herting, C. J., Karpovsky, I., & Lesinski, G. B. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09988-w · Cited by 60
Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells
Kim, S., Zingler, M., Harrison, J. K., Scott, E. W., Cogle, C. R., Luo, D., & Raizada, M. K. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06474 · Cited by 61
Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives
Nhu, Q. M., & Aceves, S. S. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00128 · Cited by 61
High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
Lipton, A., Leitzel, K. E., Ali, S. M., Polimera, H. V., Nagabhairu, V., Marks, E. I., Richardson, A. E., Krecko, L., Ali, A., Koestler, W. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31627 · Cited by 60
Advances in Cell Scaffolds for Tissue Engineering: The Value of Liquid Crystalline Elastomers
Martella, D., & Parmeggiani, C. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201800477 · Cited by 58
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
Hu, M., & Huang, L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114137 · Cited by 60
Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery
Li, Y., Sun, H., Cao, D. S., Guo, Y., Wu, D., Yang, M., Wang, H., Shao, X., Li, Y., & Liang, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s497510 · Cited by 60
Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma
Kumar, V., Boucher, Y., Liu, H., Ferreira, D. S., Hooker, J. M., Catana, C., Hoover, A. J., Ritter, T., Jain, R. K., & Guimarães, A. R. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.07.004 · Cited by 58
Self-citation
The role of tumor microenvironment and exosomes in dormancy and relapse
Attaran, S., & Bissell, M. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.008 · Cited by 57
The renin–angiotensin system in the breast and breast cancer
Vinson, G. P., Barker, S., & Puddefoot, J. R. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0335 · Cited by 56
Cancer cell mechanobiology: a new frontier for cancer research
Yu, W., Sharma, S., Rao, E., Rowat, A. C., Gimzewski, J. K., Han, D. C., & Rao, J. (2021) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2021.11.007 · Cited by 55
A collagen‐binding EGFR single‐chain Fv antibody fragment for the targeted cancer therapy
Liang, H., Li, X., Chen, B., Wang, B., Zhao, Y., Zhuang, Y., Shen, H., Zhang, Z., & Dai, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.029 · Cited by 54
Engineering extracellular matrix to improve drug delivery for cancer therapy
He, X., Yang, Y., Li, L., Zhang, P., Guo, H., Liu, N., Yang, X., & Xu, F. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.029 · Cited by 54
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models
Wu, L., Vasilijić, S., Sun, Y., Chen, J., Landegger, L. D., Zhang, Y., Zhou, W., Ren, J. P., Early, S., Yin, Z., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd4816 · Cited by 53
Self-citation
Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness
Panagi, M., Pilavaki, P., Constantinidou, A., & Stylianopoulos, T. (2022) · Theranostics · doi:10.7150/thno.72800 · Cited by 59
Local bone marrow renin–angiotensin system in primitive, definitive and neoplastic haematopoiesis
Haznedaroğlu, İ. C., & Beyazıt, Y. (2012) · Clinical Science · doi:10.1042/cs20120300 · Cited by 55
How fibrosis influences imaging and surgical decisions in pancreatic cancer
Erkan, M., Hausmann, S., Michalski, C. W., Schlitter, A. M., Fingerle, A. A., Dobritz, M., Frieß, H., & Kleeff, J. H. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00389 · Cited by 54
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors
Roehrig, F., Vorlová, S., Hoffmann, H., Wartenberg, M., Escorcia, F. E., Keller, S., Tenspolde, M., Weigand, I., Gätzner, S., Manova, K., et al. (2016) · Oncogene · doi:10.1038/onc.2016.182 · Cited by 54
AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion
Ma, Y., Xia, Z., Ye, C., Lu, C., Zhou, S., Pan, J., Liu, C., Zhang, J., Liu, T., Hu, T., et al. (2019) · Aging · doi:10.18632/aging.102032 · Cited by 54
Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model
Li, W., Li, P., Li, N., Du, Y. M., Lü, S., Elad, D., & Long, M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00379.2019 · Cited by 53
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells
Gu, L., Zhu, Y., Lee, M., Nguyen, A., Ryujin, N. T., Huang, J. Y., Pandit, S. K., Chamseddine, S., Xiao, L., Mohamed, Y. I., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300706120 · Cited by 54
Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination
Avagliano, A., Fiume, G., Ruocco, M. R., Martucci, N., Vecchio, E., Insabato, L., Russo, D., Accurso, A., Masone, S., Montagnani, S., et al. (2020) · Cancers · doi:10.3390/cancers12061697 · Cited by 56
Responsive and activable nanomedicines for remodeling the tumor microenvironment
Zhang, Y., Han, X., & Nie, G. (2020) · Nature Protocols · doi:10.1038/s41596-020-00421-0 · Cited by 51
Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer
Yang, X., Zhang, J., Zhou, Q.-M., Yu, J., Lu, Y., Wang, X., Zhou, J.-P., Ding, X.-F., Du, Y., & Yu, R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01738-6 · Cited by 56
Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles
Sakurai, Y., Hada, T., Yamamoto, S., Kato, A., Mizumura, W., & Harashima, H. (2016) · Molecular Therapy · doi:10.1038/mt.2016.178 · Cited by 53
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy
Torphy, R. J., Schulick, R. D., & Zhu, Y. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23179 · Cited by 54
Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab
Levin, V. A., Chan, J., Datta, M., Yee, J. L., & Jain, R. K. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2528-3 · Cited by 51
Self-citation
Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Lei, F., Xi, X., Batra, S. K., & Bronich, T. K. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255786 · Cited by 51
In silico dynamics of COVID-19 phenotypes for optimizing clinical management
Voutouri, C., Nikmaneshi, M. R., Hardin, C. C., Patel, A. B., Verma, A., Khandekar, M. J., Dutta, S., Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021642118 · Cited by 47
Self-citation
Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions
Jenkins, B. H., Buckingham, J. F., Hanley, C. J., & Thomas, G. J. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108231 · Cited by 56
Cleavable collagenase-assistant nanosonosensitizer for tumor penetration and sonodynamic therapy
Yin, T., Chen, H., Ma, A.-Q., Pan, H., Chen, Z., Tang, X., Huang, G., Liao, J., Zhang, B., Zheng, M., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121992 · Cited by 53
In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant
Zhang, H., Zhang, Y., Hu, H., Yang, W., Xia, X., Lei, L., Lin, R., Li, J., Li, Y., & Gao, H. (2023) · Small · doi:10.1002/smll.202301041 · Cited by 51
Losartan Improves Adipose Tissue-Derived Stem Cell Niche by Inhibiting Transforming Growth Factor-β and Fibrosis in Skeletal Muscle Injury
Park, J., Ki, M.-R., Lee, E. M., Kim, A.-Y., You, S., Han, S., Lee, E. H., Hong, I., Kwon, S., Kim, S., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x637055 · Cited by 51
Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity
Yu, M., Zhang, C., Tang, Z., Tang, X., & Xu, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.011 · Cited by 51
Angiotensin Inhibition, TGF-β and EMT in Cancer
Pallasch, F. B., & Schumacher, U. (2020) · Cancers · doi:10.3390/cancers12102785 · Cited by 51
Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
Zhao, Q. S., He, X., Qin, X., Liu, Y., Jiang, H., Wang, J., Wu, S., Zhou, R., Yu, C., Liu, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938439 · Cited by 51
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy
Baldari, S., Modugno, F. D., Nisticò, P., & Toietta, G. (2022) · Cancers · doi:10.3390/cancers14194706 · Cited by 53
Breaking‐Down Tumoral Physical Barrier by Remotely Unwrapping Metal‐Polyphenol‐Packaged Hyaluronidase for Optimizing Photothermal/Photodynamic Therapy‐Induced Immune Response
Sun, Q., Li, Y., Shen, W. H., Shang, W., Xu, Y., Yang, J., Chen, J., Gao, W., Wu, Q., Xu, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202310673 · Cited by 50
Multiple aspects of matrix stiffness in cancer progression
Mancini, A., Gentile, M. T., Pentimalli, F., Cortellino, S., Grieco, M., & Giordano, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1406644 · Cited by 58
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
Stylianopoulos, T., Wong, C., Bawendi, M. G., Jain, R. K., & Fukumura, D. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00006-9 · Cited by 52
Self-citation
Desmoplasia and chemoresistance in pancreatic cancer
Whatcott, C. J., Posner, R. G., Hoff, D. D. V., & Han, H. (2012) · Europe PMC (PubMed Central) · Cited by 50
GPCR Modulation in Breast Cancer
Lappano, R., Jacquot, Y., & Maggiolini, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123840 · Cited by 51
Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice
Zhang, B., Jin, K., Jiang, T., Wang, L., Shen, S., Luo, Z., Tuo, Y., Liu, X., Hu, Y., & Pang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-09520-7 · Cited by 49
The biomimetic extracellular matrix: a therapeutic tool for breast cancer research
Tamayo-Angorrilla, M., de Andrés, J. L., Jiménez, G., & Marchal, J. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.008 · Cited by 51
Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy
Goins, B., Phillips, W. T., & Bao, A. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1167035 · Cited by 52
Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma
Martínez-Zubiaurre, I., Chalmers, A. J., & Hellevik, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01679 · Cited by 52
A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix
Liang, H., Li, X., Wang, B., Chen, B., Zhao, Y., Sun, J., Zhuang, Y., Shi, J., Shen, H., Zhang, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep18205 · Cited by 50
The Neuroprotective Effect of Irisin in Ischemic Stroke
Liu, Y., Zhu, C., Guo, J., Chen, Y., & Meng, C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.588958 · Cited by 49
Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine
Cassani, M., Fernandes, S., Pagliari, S., Cavalieri, F., Caruso, F., & Forte, G. (2025) · Advanced Science · doi:10.1002/advs.202409898 · Cited by 48
Physical oncology: New targets for nanomedicine
Nicolás‐Boluda, A., Silva, A., Fournel, S., & Gazeau, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.014 · Cited by 48
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Yokoda, R. T., Nagalo, B. M., Vernon, B. L., Öklü, R., Albadawi, H., DeLeon, T., Zhou, Y., Egan, J. B., Duda, D. G., & Borad, M. J. (2017) · Oncolytic Virotherapy · doi:10.2147/ov.s145262 · Cited by 49
Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems
Zafar, S., Beg, S., Panda, S. K., Rahman, M., Alharbi, K. S., Jain, G. K., & Ahmad, F. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.023 · Cited by 48
Breast Cancer CAFs: Spectrum of Phenotypes and Promising Targeting Avenues
Elwakeel, E., & Weigert, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111636 · Cited by 49
MR Imaging Biomarkers in Oncology Clinical Trials
Abramson, R. G., Arlinghaus, L. R., Dula, A. N., Quarles, C. C., Stokes, A. M., Weis, J. A., Whisenant, J. G., Chekmenev, E. Y., Юрьевич, Ж. И., Williams, J. M., et al. (2015) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2015.08.002 · Cited by 47
Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer
Xia, T., He, Q., Shi, K., Wang, Y., Yu, Q., Zhang, L., Zhang, Q., Gao, H., Ma, L., & Liu, J. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1265553 · Cited by 51
Dual nanofiber scaffolds composed of polyurethane- gelatin/nylon 6- gelatin for bone tissue engineering
Ali, M. G., Mousa, H. M., Blaudez, F., El-sadek, M. S. A., Mohamed, M. A., Abdel-Jaber, G. T., Abdal‐hay, A., & Ivanovski, S. (2020) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2020.124817 · Cited by 47
Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles
Yamamoto, S., Kato, A., Sakurai, Y., Hada, T., & Harashima, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.010 · Cited by 48
Role of Endocytosis in Nanoparticle Penetration of 3D Pancreatic Cancer Spheroids
Durymanov, M. O., Kroll, C., Permyakova, A., & Reineke, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01078 · Cited by 46
Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges
Li, W., Little, N., Park, J., Foster, C. A., Chen, J., & Lu, J. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00455 · Cited by 46
The tumor microenvironment: a key player in multidrug resistance in cancer
Meng, L., Zheng, Y., Liu, H., & Fan, D. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0459 · Cited by 47

Authors: Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K.
Affiliations: Harvard University (US)
Corresponding author: Jain, Rakesh K.
ORCID: Chauhan, Vikash P.
Boucher, Yves
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2011-01-31
Volume: 108
Issue: 7
Pages: 2909-2914
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1018892108
PMC: PMC3041115
OpenAlex: W2098054841
Cited by: 733
References: 54
Citations by year: 2026: 38 · 2025: 51 · 2024: 63 · 2023: 55 · 2022: 65 · 2021: 77 · 2020: 84 · 2019: 47 · 2018: 43 · 2017: 51 · 2016: 40 · 2015: 40 · 2014: 20 · 2013: 28 · 2012: 24
FWCI: 10.23
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders: U.S. Department of Defense (W81XWH1010016, W81XWH)
AstraZeneca
FibroGen
Astellas Pharma
National Cancer Institute (W81XWH-10-1-0016, R01 CA 85140, R01CA98706, R01CA085140, P01CA080124, R01CA098706, P01-CA-80124)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords: losartan, collagen I synthesis, desmoplasia, tumor stroma, nanotherapeutics, drug penetration, oncolytic herpes simplex virus, pegylated liposomal doxorubicin, cancer-associated fibroblasts, breast cancer, pancreatic cancer, skin cancer, antifibrotic agents, tumor microenvironment
MeSH terms: Analysis of Variance, Animals, Breast Neoplasms, Carcinoma, Collagen, Dose-Response Relationship, Drug, Doxorubicin, Female, Humans, Immunohistochemistry, Pancreatic Neoplasms, Polyethylene Glycols, Skin Neoplasms, Polymerase Chain Reaction, Drug Delivery Systems, Mice, SCID, DNA Primers, Simplexvirus, Losartan, Nanotechnology, Fluorescence Recovery After Photobleaching, Oncolytic Virotherapy, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks